Recombinant Mouse Interleukin 28B, His-tag, MBP-tag
|Product Overview :||Recombinant Mouse Interleukin 28B has the matured 174 aa at its C terminal, His tag and MBP tag at the N terminal. It is expressed and purified from an E.coli system.|
- Gene Information
- Related Products
|Cat. No. :||IL28B-214M|
|Description :||This gene encodes a cytokine distantly related to type I interferons and the IL-10 family. This gene, interleukin 28A (IL28A), and interleukin 29 (IL29) are three closely related cytokine genes that form a cytokine gene cluster on a chromosomal region mapped to 19q13. Expression of the cytokines encoded by the three genes can be induced by viral infection. All three cytokines have been shown to interact with a heterodimeric class II cytokine receptor that consists of interleukin 10 receptor, beta (IL10RB) and interleukin 28 receptor, alpha (IL28RA).|
|Source :||E. coli|
|Molecular Mass :||63.3 kD|
|Formulation :||20 mM Tris-Cl (pH 7.9) 20% Glycerol, 100 mM KCl, 1 mM DTT and 0.2 mM EDTA|
|Purity :||>95% based on SDS-PAGE analysis|
|Concentration :||500 µg/ml|
|Reconsitution :||Already in liquid form.|
|Storage :||-80 °C|
|Shipping Conditions :||Dry Ice|
|Gene Name :||Il28b interleukin 28B [ Mus musculus ]|
|Synonyms :||Il28b; interleukin 28B; Il28; IFL-1; INF-alpha; IL-28B INF-lambda; interleukin 28; interferon alpha; IFNL3; IL28C; interleukin-28B; IFN-lambda-3; interferon lambda-3|
|Gene ID :||338374|
|mRNA Refseq :||NM_177396|
|Protein Refseq :||NP_796370|
|UniProt ID :||Q8CGK6|
|Chromosome Location :||7 A3; 7|
|Pathway :||Jak-STAT signaling pathway|
|Function :||cytokine activity; receptor binding|
|◆ Recombinant Protein|
|IL28B-4512M||Recombinant Mouse IL28B Protein, His (Fc)-Avi-tagged||+Inquiry|
|IL28B-4370E||Recombinant Equine IL28B Protein||+Inquiry|
|IL28B-2308H||Recombinant Human IL28B Protein, His-tagged||+Inquiry|
|IL28B-605H||Active Recombinant Human IL28B||+Inquiry|
|IL28B-379H||Recombinant Human IL28B, His tagged||+Inquiry|
For Research Use Only. Not intended for any clinical use. No products from Creative BioMart may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative BioMart.
Q&As (6)Ask a question
IL28B has achieved remarkable results in the treatment of hepatitis C. The study found that patients with a specific genotype, which is related to IL28B, were better able to benefit from treatment with the hepatitis drug interferon. Therefore, the combination of IL28B with other drugs can improve the efficacy.
IL28B can regulate the immune response of cells and promote the occurrence of insulin-dependent cytotoxicity mediated by NK cells, thus playing an antiviral role.
The purification methods of IL28B include ion exchange, gel filtration, affinity chromatography, countercurrent chromatography, etc.
The dose of treatment with IL28B varies depending on the patient. When treating hepatitis C, the dose is usually given once a week, 500ug or another dose.
The adverse reactions of IL28B include fever, headache, fatigue, muscle aches, nausea, diarrhea and other symptoms, and in severe cases, allergic reactions and liver damage.
IL28B will have a certain impact on the function of other organs of the body, such as the liver, kidneys, etc., but the use of normal doses in clinical practice is generally safe.
Customer Reviews (3)Write a review
Evaluate the purity of recombinant IL-28B protein to ensure that there are no impurities in it. -
The regulation effect of recombinant IL-28B protein on cell signal transduction pathway, such as immune response and antiviral, was verified by cell experiments. To evaluate its blocking effect on pathogen infection and understand its potential in the treatment of infectious diseases. -
To investigate the effect of recombinant IL-28B protein on the immune system and evaluate whether it can cause immune response, especially the production of neutralized antibodies. -
Ask a Question for All Il28b Products
Required fields are marked with *
My Review for All Il28b Products
Required fields are marked with *